OnCo

NSD1 (Histone-lysine N-methyltransferase, H3 lysine-36 specific) is a protein that switches other genes on and off. The public catalogues list it as an oncogene driver, a tumour suppressor and a fusion partner, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Leukaemia, Myeloproliferative neoplasms, Head and neck squamous cell carcinoma and 5 more. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.

Biology

Histone methyltransferase that dimethylates Lys-36 of histone H3 (H3K36me2). Transcriptional intermediary factor capable of both negatively or positively influencing transcription, depending on the cellular context. Location: Nucleus; Chromosome (UniProt). Locus 5q35.3 (HGNC).

Where it is found
  • Leukaemia: Open Targets association 0.67 with leukaemia (MONDO_0005059)
  • Myeloproliferative neoplasms: Open Targets association 0.66 with myeloproliferative neoplasm (MONDO_0020076)
  • Head and neck squamous cell carcinoma: Open Targets association 0.54 with head and neck squamous cell carcinoma (MONDO_0010150); IntOGen driver in 4 cohorts (HNSC)
  • Endometrial cancer: IntOGen driver in 2 cohorts (UCEC)
  • Bladder & urothelial cancer: IntOGen driver in 1 cohort (BLCA)
  • Cervical cancer: IntOGen driver in 1 cohort (CEAD)
Class: transcription · Gene: NSD1 · Facts checked 2026-09-23 · Target page

External identifiers

Built from HGNC, Ensembl, UniProt and ChEMBL ids

Products by modality and phase

Browse products →

No product in the corpus is aimed at this target yet.

No trial in the corpus names this target or one of its products.

Resistance routes

Unaddressed routes →

The resistance atlas has no route that names this target.

No pathway diagram carries this target as a node.

Companion diagnostics

Assay registry →

No companion diagnostic in the registry measures this target.

Preclinical models

All models →

No model entry for this target yet; check the cancer entries on the models page.

No open questions recorded for this target yet. Suggest one.

Literature

Preprints →
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this target: (TITLE:"NSD1" OR ABSTRACT:"NSD1" OR TITLE:"nuclear receptor binding SET domain protein 1" OR ABSTRACT:"nuclear receptor binding SET domain protein 1" OR TITLE:"Histone-lysine N-methyltransferase, H3 lysine-36 specific" OR ABSTRACT:"Histone-lysine N-methyltransferase, H3 lysine-36 specific" OR TITLE:"ARA267" OR ABSTRACT:"ARA267" OR TITLE:"FLJ22263" OR ABSTRACT:"FLJ22263" OR TITLE:"KMT3B" OR ABSTRACT:"KMT3B") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about NSD1, not a curated reading list.

Export

The dossier as machine-readable JSON: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/nsd1.json. Licence CC BY-NC 4.0.